Alembic Pharmaceuticals received USFDA approval for its Sumatriptan injection, a generic equivalent for treating migraines and cluster headaches. This marks Alembic's first drug device combination.
Alembic Pharma receives US FDA final approval for sumatriptan injection USP, 4 mg/0.5 mL and 6 mg/0.5 mL, single-dose autoinjector system: Our Bureau, Mumbai Monday, November 10, ...
Ltd on Monday said it has received final approval from the US health regulator for its generic version of Sumatriptan injection used in treatment of migraine. The approval by the US Food & Drug ...
Tonmya™ (cyclobenzaprine HCl sublingual tablets) for the treatment of fibromyalgia set to launch in November Tonmya is the ...
Indian stocks ended higher on Monday, with the Sensex and Nifty mirroring gains across Asian markets amid optimism that ...
HAMILTON, ON, Nov. 12, 2025 /CNW/ – AtomVie Global Radiopharma (AtomVie), a leading radiopharmaceutical CDMO, announced that ...
Cluster headache is one of the most severe and disabling primary headache disorders, though it often goes undiagnosed for years.
Vadodara: Pharma firm Alembic Pharmaceuticals Limited has announced that the company has received final approval from the US Food & Drug Administration (USFDA) for its Abbreviated New ...
The Board of Directors of Vapi Enterprises Limited, at its meeting held today have approved the financial results of the ...
Hindustan Aeronautics Ltd has entered into an agreement with M/s. General Electric Company, USA, on 7th November 2025 for the supply of 113 Nos of F404-GE-IN20 engines and support package for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback